The study revealed that FXR differentially acted on glucose metabolism in lean and obese conditions and FXR in adipose tissue contributed to the dysregulation of glucose metabolism in obesity. The gene discussed is NR1H4; the disease is obesity due to melanocortin 4 receptor deficiency.